Hear from an expert about self-collection in a healthcare setting

Be at the forefront of cervical cancer screening with BD Onclarity™ HVP Assay, the first and only FDA-approved HPV assay offering both extended genotyping and self-collection in a healthcare setting.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis
Vaginitis | News & Updates
Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis
Molly Broache, Associate Director, Medical Affairs for US IDS discusses the future of cervical cancer screening
Cervical Cancer | News & Updates
Clinical Lab Products: The Future of Cervical Cancer Screening is Here
Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD
Cervical Cancer | News & Updates
NJBIZ Conversations: Chris Beddard